‘Rhoda’ Actress’s Cancer Miracle
Valerie Harper Image by getty images
Actress Valerie Harper’s brain cancer is nearing remission, her physician said in an excerpt of a documentary that was shown on NBC’s “Today” show.
“I’d say that we’re getting pretty close to remission,” neuro-oncologist Dr. Jeremy Rudnick said in a documentary that will air next month on the U.S. network.
“It defies the odds,” he added, as Harper sat listening to the results of tests conducted in June.
Harper, 74, won four Emmy Awards for her signature role of Rhoda Morgenstern on the hit 1970s sitcoms “The Mary Tyler Moore Show” and spin-off “Rhoda.” The actress said in March that her diagnosis of leptomeningeal carcinomatosis – cancer in the membrane of her brain – meant she had as little as three months to live.
In June, NBC announced that it was shooting a documentary about Harper and her treatment.
Rudnick cautioned in the segment that resistance to treatment is all-but-assured, saying, “it’s not a matter of if, but of when.” The actress has received treatment ranging from chemotherapy to acupuncture.
“I am afraid of what’s ahead,” Harper said. “But, so what? There’s much to be afraid of in life.”
Harper completed a tour promoting her new autobiography “I, Rhoda” shortly before going public with her illness. Last year she starred on Broadway as actress Tallulah Bankhead in “Looped,” for which she earned a Tony nomination.
Harper has continued to work since her diagnosis, notably in an upcoming episode of the cable comedy series “Hot in Cleveland” in which she guest-starred with former cast mates Mary Tyler Moore, Cloris Leachman and series regular Betty White.
A message from our CEO & publisher Rachel Fishman Feddersen
I hope you appreciated this article. Before you move on, I wanted to ask you to support the Forward’s award-winning journalism during our High Holiday Monthly Donor Drive.
If you’ve turned to the Forward in the past 12 months to better understand the world around you, we hope you will support us with a gift now. Your support has a direct impact, giving us the resources we need to report from Israel and around the U.S., across college campuses, and wherever there is news of importance to American Jews.
Make a monthly or one-time gift and support Jewish journalism throughout 5785. The first six months of your monthly gift will be matched for twice the investment in independent Jewish journalism.
— Rachel Fishman Feddersen, Publisher and CEO
